Five months before Colorado’s Prescription Drug Affordability Board will vote on how much to cap the cost of Amgen’s Enbrel, the drugmaker filed a lawsuit.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Amgen sues Colorado for potential price limit on arthritis drug
